Zika Virus Clinical Trial
Official title:
Double Blinded, Randomized, Placebo Controlled, Dose Finding Trial to Evaluate the Optimal Dose of MV-ZIKA, a New Vaccine Against Zika Virus, in Regard to Immunogenicity, Safety, and Tolerability in Healthy Volunteers
Double blinded, randomized, placebo-controlled, dose finding, multi-center, phase 1 trial in 48 healthy volunteer subjects. After completion of screening procedures, the subjects are randomized to one of four treatment groups (different dosage strengths and placebo) All subjects will receive study treatment at day 0 and will return on day 28. Subjects randomized to treatment groups with two vaccinations will receive a second treatment at day 28. Subjects will return on day 56 for the final visit.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT04182685 -
Evaluation of Medical Conditions Associated With Zika Virus Infection in Managua, Nicaragua
|
||
| Enrolling by invitation |
NCT04398901 -
Neurodevelopmental Outcomes in ZIKV-Exposed Children
|
||
| Completed |
NCT03188731 -
ZIKAlliance Pregnant Women Cohort
|
||
| Completed |
NCT03110770 -
VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents
|
Phase 2 | |
| Active, not recruiting |
NCT04917861 -
A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas
|
Phase 2 | |
| Completed |
NCT02794181 -
Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)
|
||
| Recruiting |
NCT01099852 -
Cohort of Patients Infected by an Arbovirus
|
||
| Completed |
NCT03611946 -
Evaluation of the Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults
|
Phase 1 | |
| Completed |
NCT04064905 -
Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults
|
Phase 1 | |
| Completed |
NCT03106714 -
Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
|
||
| Completed |
NCT02979938 -
Understanding Excretion and Infectivity of Zika Virus in Semen During and After Infection
|
||
| Recruiting |
NCT03227601 -
Effect of a Posture Adapter for 12 to 24-month Children With Zyka Virus Syndrome
|
N/A | |
| Completed |
NCT03393286 -
ZIKAlliance Children Cohort (ZIKAllianceCH)
|
||
| Completed |
NCT03425149 -
Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults
|
Phase 1 | |
| Recruiting |
NCT05123222 -
Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)
|
Phase 1 | |
| Completed |
NCT02733796 -
Persistence of Zika Virus in Semen After Acute Infection
|
||
| Completed |
NCT03014089 -
Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects
|
Phase 1 | |
| Completed |
NCT03263195 -
Prospective Cohort Study of HIV and Zika in Infants and Pregnancy
|
||
| Withdrawn |
NCT03204409 -
ZIKAlliance Natural History Study
|